"The research indicates the risk, although rare, is almost five times higher with Wegovy than it is with Ozempic, and three times greater in men than it is in women, according to the study published in the British Journal of Ophthalmology."
A new analysis published in the British Journal of Ophthalmology reveals that Wegovy, a weight-loss medication, carries a significantly elevated risk of eye stroke and sudden vision loss compared to other weight-loss drugs. Although rare, the risk associated with Wegovy is approximately five times higher than with Ozempic. The research also identifies a notable gender disparity, showing that men experience three times greater risk than women. These findings raise important safety considerations for patients considering or currently using Wegovy for weight management.
#wegovy-safety #eye-stroke-risk #weight-loss-medications #vision-loss #gender-differences-in-drug-side-effects
Read at Independent
Unable to calculate read time
Collection
[
|
...
]